Laddar...
Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting
PURPOSE: Imatinib inhibits platelet-derived growth factor receptor (PDGFR), and evidence shows that PDGFR participates in the development and progression of cervical cancer. Although imatinib has exhibited preclinical activity against cervical cancer, only minimal clinical therapeutic efficacy was o...
Sparad:
| Huvudupphovsmän: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019625/ https://ncbi.nlm.nih.gov/pubmed/24855354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S60178 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|